Stage-Oriented CT Classification and Intermodal Evolution Model in Hepatic Alveolar Echinococcosis

Abstract

Background

Alveolar echinococcosis (AE) is one of the most dangerous human parasitoses. The main site of disease manifestation is the liver (about 98 %). The Echinococcus Multilocularis Ulm Classification for Computed Tomography (EMUC-CT), presented in 2016, was the first compilation of CT morphological criteria of hepatic AE. Studies based on EMUC-CT made it possible to draw conclusions about the development of the lesions in the course of disease beyond purely diagnostic typing. Among the most important findings of these precursor studies was that EMUC-CT type IV presented as an initial lesion, whereas EMUC-CT type III lesions were mostly associated with an advanced disease constellation. An intermodal view of image morphological criteria provides further multi-layered indications for lesion evolution.

Method

With the “Alveolar Echinococcosis Ulm Classification” (AEUC), a revision of the previous EMUC-CT was carried out with stage-oriented reorganization of the primary morphologies. Furthermore, an intermodal classification scheme for the evolution of hepatic AE lesions based on AEUC, MRI Kodama classification, and aspects of ultrasound could be outlined.

Results

The first stage-oriented CT classification of hepatic AE “AEUC” is based with respect to its lesion characterization on the separate consideration of two classification pillars, the five “primary morphologies”, AEUC I–V (AEUC II–IV with subcriteria) and the five “patterns of calcification”. In addition, an intermodal classification scheme presents five stages of lesion evolution: “initial stage”, “progressive stage”, “advanced stage”, “transitional stage” and “regressive stage”.

Conclusion

The imaging modalities differ with respect to their visualization of lesion criteria. This underlines the need for unimodal classification systems. Staging of an AE lesion can be done more accurately by evaluating different modalities.

Key Points:

• The AEUC provides a stage-oriented CT classification for hepatic AE.

• Aspects of different modalities allow a more multi-layered view of lesion evolution.

• More accurate staging can be achieved by combining different modalities.

Citation Format

• Graeter T, Schmidberger J. Stage-Oriented CT Classification and Intermodal Evolution Model in Hepatic Alveolar Echinococcosis. Fortschr Röntgenstr 2022; 194: 532 – 544

Key words

computed tomography - intermodal classification - lesion evolution - alveolar echinococcosis

Publikationsverlauf

Eingereicht: 25. Juni 2021

Angenommen: 14. Oktober 2021

Artikel online veröffentlicht:
26. Januar 2022

• References

• 1 Kern P, Bardonnet K, Renner E. et al. European echinococcosis registry: human alveolar echinococcosis, Europe, 1982–2000. Emerg Infect Dis 2003; 9: 343-349
• 2 Moro P, Schantz PM. Echinococcosis: a review. Int J Infect Dis 2009; 13: 125-133
• 3 Baumann S, Shi R, Liu W. et al. Worldwide literature on epidemiology of human alveolar echinococcosis: a systematic review of research published in the twenty-first century. Infection 2019; 47: 703-727
• 4 Romig T, Kratzer W, Kimmig P. et al. An epidemiologic survey of human alveolar echinococcosis in southwestern Germany. Römerstein Study Group. Am J Trop Med Hyg 1999; 61: 566-573
• 5 Torgerson PR, Keller K, Magnotta M. et al. The global burden of alveolar echinococcosis. PLoS Negl Trop Dis 2010; 4: e722
• 6 Deplazes P, Rinaldi L, Alvarez Rojas CA. et al. Global Distribution of Alveolar and Cystic Echinococcosis. Adv Parasitol 2017; 95: 315-493
• 7 Zhang W, Zhang Z, Wu W. et al. Epidemiology and control of echinococcosis in central Asia, with particular reference to the People’s Republic of China. Acta Trop 2015; 141: 235-243
• 8 Craig PS. Echinococcosis Working Group in China. Epidemiology of human alveolar echinococcosis in China. Parasitol Int 2006; 55: 221-225
• 9 Conraths FJ, Probst C, Possenti A. et al. Potenzial risk factors associated with human alveolar echinococcosis: Systematic review and meta-analysis. PLoS Negl Trop Dis 2017; 11: e0005801
• 10 Ammann RW, Eckert J. Cestodes. Echinococcus. Gastroenterol Clin North Am 1996; 25: 655-689
• 11 Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev 2004; 17: 107-135
• 12 Hillenbrand A, Gruener B, Kratzer W. et al. Impact of Safe Distance on Long-Term Outcome After Surgical Therapy of Alveolar Echinococcosis. World J Surg 2017; 41: 1012-1018
• 13 Graeter T, Ehing F, Oeztuerk S. et al. Hepatobiliary complications of alveolar echinococcosis: A long-term follow-up study. World J Gastroenterol 2015; 21: 4925-4932
• 14 Brunetti E, Kern P, Vuitton DA. Writing Panel for the WHO-IWGE. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop 2010; 114: 1-16
• 15 Kaltenbach TE, Graeter T, Mason RA. et al. Determination of vitality of liver lesions by alveolar echinococcosis. Comparison of parametric contrast enhanced ultrasound (SonoVue^®) with quantified 18F-FDG-PET-CT. Nuklearmedizin 2015; 54: 43-49
• 16 Ricken FJ, Nell J, Grüner B. et al. Albendazole increases the inflammatory response and the amount of Em2-positive small particles of Echinococcus multilocularis (spems) in human hepatic alveolar echinococcosis lesions. PLoS Negl Trop Dis 2017; 11: e0005636
• 17 Kodama Y, Fujita N, Shimizu T. et al. Alveolar echinococcosis: MR findings in the liver. Radiology 2003; 228: 172-177
• 18 Kratzer W, Gruener B, Kaltenbach TE. et al. Proposal of an ultrasonographic classification for hepatic alveolar echinococcosis: Echinococcosis multilocularis Ulm classification-ultrasound. World J Gastroenterol 2015; 21: 12392-12402
• 19 Graeter T, Kratzer W, Oeztuerk S. et al. Proposal of a computed tomography classification for hepatic alveolar echinococcosis. World J Gastroenterol 2016; 22: 3621-3631
• 20 Grüner B, Schmidberger J, Drews O. et al. Imaging in alveolar echinococcosis (AE): Comparison of Echinococcus multilocularis classification for computed-tomography (EMUC-CT) and ultrasonography (EMUC-US). Radiology of Infectious Diseases 2017; 4: 70-77
• 21 Kern P, Wen H, Sato N. et al. WHO classification of alveolar echinococcosis: principles and application. Parasitol Int 2006; (Suppl. 55) S283-S287
• 22 Graeter T, Shi R, Bao HH. et al. Follow-up in hepatic alveolar echinococcosis under benzimidazole therapy using computed tomography. Chin Med J (Engl) 2020; 133: 1507-1509
• 23 Graeter T, Bao H, Delabrousse E. et al. Hepatic alveolar echinococcosis: Comparative computed tomography study between two Chinese and two European centres. Chin Med J (Engl) 2020; 19: e00082
• 24 Graeter T, Bao HH, Shi R. et al. Evaluation of intrahepatic manifestation and distant extrahepatic disease in alveolar echinococcosis. World J Gastroenterol 2020; 26: 4302-4315
• 25 Engler A, Shi R, Beer M. et al. Simple liver cysts and cystoid lesions in hepatic alveolar echinococcosis: A retrospective cohort study with Hounsfield analysis. Parasite 2019; 26: 54
• 26 Graeter T, Eberhardt N, Shi R. et al. Hepatic alveolar echinococcosis: Correlation between computed tomography morphology and inflammatory activity in positron emission tomography. Sci Rep 2020; 10: 11808
• 27 Grimm J, Beck A, Nell J. et al. Combining Computed Tomography and Histology Leads to an Evolutionary Concept of Hepatic Alveolar Echinococcosis. Pathogens 2020; 9: 634
• 28 Brumpt E, Blagosklonov O, Calame P. et al. AE hepatic lesions: correlation between calcifications at CT and FDG-PET/CT metabolic activity. Infection 2019; 47: 955-960
• 29 Azizi A, Blagosklonov O, Lounis A. et al. Alveolar echinococcosis: correlation between hepatic MRI findings and FDG-PET/CT metabolic activity. Abdominal Imaging 2015; 40: 56-63
• 30 Graeter T, Shi R, Bao HH. et al. Intrahepatic manifestation and distant extrahepatic disease in alveolar echinococcosis: a multicenter cohort study. Acta Radiol 2020;
• 31 Brumpt W, Liu W, Graeter T. et al Kodama-XUUB: an informative classification for alveolar echinococcosis hepatic lesions at MRI. Parasite. In press.
• 32 Aoki T, Hagiwara M, Yabuki H. et al. Unique MRI findings for differentiation of an early stage of hepatic alveolar echinococcosis. BMJ Case Rep 2015; 2015
• 33 Becce F, Pomoni A, Uldry E. et al. Alveolar echinococcosis of the liver: diffusion-weighted MRI findings and potential role in lesion characterisation. Eur J Radiol 2014; 83: 625-631
• 34 Liu W, Delabrousse É, Blagosklonov O. et al. Innovation in hepatic alveolar echinococcosis imaging: best use of old tools, and necessary evaluation of new ones. Parasite 2014; 21: 74
• 35 Parry AH, Wani AH, Feroz I. The spectrum of multimodality imaging findings in hepatic alveolar echinococcosis and the potential role of diffusion-weighted imaging in its characterisation. Pol J Radiol 2020; 85: e613-e623
• 36 Tappe D, Zidowitz S, Demmer P. et al. Three-dimensional reconstruction of Echinococcus multilocularis larval growth in human hepatic tissue reveals complex growth patterns. Am J Trop Med Hyg 2010; 82: 126-127
• 37 Reinehr M, Micheloud C, Grimm F. et al. Pathology of Echinococcosis: A Morphologic and Immunohistochemical Study on 138 Specimens With Focus on the Differential Diagnosis Between Cystic and Alveolar Echinococcosis. Am J Surg Pathol 2020; 44: 43-54
• 38 Barth TF, Herrmann TS, Tappe D. et al. Sensitive and specific immunohistochemical diagnosis of human alveolar echinococcosis with the monoclonal antibody Em2G11. PLoS Negl Trop Dis 2012; 6: e1877
• 39 Deplazes P, Gottstein B. A monoclonal antibody against Echinococcus multilocularis Em2 antigen. Parasitology 1991; 103: 41-49
• 40 Gottstein B, Lachenmayer A, Beldi G. et al. Diagnostic and follow-up performance of serological tests for different forms/courses of alveolar echinococcosis. Food Waterborne Parasitol 2019; 16: e00055